Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study - Castro, M; Mathur, S; Hargreave, F; Boulet, L P; Xie, F; Young, J; Wilkins, H J; Henkel, T; Nair, P (Am J Respir Crit Care Med, 2011)